A Study of Pembrolizumab and Olaparib in People With Endometrial Cancer or Endometrial Carcinosarcoma
Clinical trial NCT05156268 · COMPLETED
Trial details
- NCT number
- NCT05156268
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-27
- Primary completion
- 2026-04-24
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.